Home > News
News
SINOVAC Polio Vaccine Prequalified by WHO
June 08, 2022 10:00 PM Eastern Daylight Time
BEIJING—(BUSINESS WIRE)—SINOVAC Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it received...
Article published in The Lancet Infectious Diseases Accelerating research and development of new vaccines against tuberculosis: a global roadmap
Authors: Prof Frank Cobelens PhDa, Rajinder Kumar Suri MScb, Michelle Helinski PhD, Michael Makanga PhDc, Ana Lúcia...
Sponsors:
